ChemicalBook >> CAS DataBase List >>KI16425

KI16425

CAS No.
355025-24-0
Chemical Name:
KI16425
Synonyms
CS-88;KI-6425;Debio 0719;Ki16425, >=98%;Ki16425 ,S1315;KI16425 USP/EP/BP;KI-16425; KI 16425;Ki16425 (Debio 0719);Ki16425, 10 mM in DMSO;KI16425;KI-16425; KI 16425
CBNumber:
CB9497429
Molecular Formula:
C23H23ClN2O5S
Molecular Weight:
474.96
MDL Number:
MFCD06798341
MOL File:
355025-24-0.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-06-03 11:24:09

KI16425 Properties

Melting point 59.5-60.5 °C
Boiling point 623.7±55.0 °C(Predicted)
Density 1.353
storage temp. -20°C
solubility DMSO: 16 mg/mL
form solid
pka 4.32±0.10(Predicted)
color white
InChI 1S/C23H23ClN2O5S/c1-14-21(25-23(29)30-15(2)18-5-3-4-6-19(18)24)22(31-26-14)17-9-7-16(8-10-17)13-32-12-11-20(27)28/h3-10,15H,11-13H2,1-2H3,(H,25,29)(H,27,28)
InChIKey LLIFMNUXGDHTRO-UHFFFAOYSA-N
SMILES S(CCC(=O)O)Cc1ccc(cc1)c2[o]nc(c2NC(=O)OC(C)c3c(cccc3)Cl)C
FDA UNII 83W49JT69B
UNSPSC Code 12352200
NACRES NA.77

SAFETY

Risk and Safety Statements

Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-36
WGK Germany  3
HS Code  29349990
Storage Class 11 - Combustible Solids

KI16425 price More Price(63)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML0971 Ki 16425 ≥98% (HPLC) 355025-24-0 5mg $129 2026-04-30 Buy
Sigma-Aldrich SML0971 Ki 16425 ≥98% (HPLC) 355025-24-0 25mg $527 2026-04-30 Buy
Cayman Chemical 10012659 Ki16425 ≥95% 355025-24-0 1mg $41 2026-04-30 Buy
Cayman Chemical 10012659 Ki16425 ≥95% 355025-24-0 5mg $108 2026-04-30 Buy
Cayman Chemical 10012659 Ki16425 ≥95% 355025-24-0 10mg $157 2026-04-30 Buy
Product number Packaging Price Buy
SML0971 5mg $129 Buy
SML0971 25mg $527 Buy
10012659 1mg $41 Buy
10012659 5mg $108 Buy
10012659 10mg $157 Buy

KI16425 Chemical Properties, Uses, Production

Description

Lysophosphatidic acid (LPA) is a bioactive lipid mediator that signals through five distinct G protein-coupled receptors (LPA1-5). Ki16425 is a LPA receptor antagonist with selectivity for LPA1 and LPA3. It exhibits Ki values of 0.34, 6.5, and 0.93 μM for the human LPA1, LPA2, and LPA3 receptors, respectively, as determined by measuring inositol phosphate production in RH7777-transfected cells. Ki1642, at 10 μM, significantly blocks the response of a variety of cancer cell lines to LPA-induced cell migration.

Uses

Ki 16425 has been used as a chemical inhibitor to study the regulation of LPA (lysophosphatidic acid) on LPAR(LPA receptor) subtypes.

Uses

Ki16425 is a competitive, potent and reversible antagonist to LPA1, LPA2 and LPA3.

Definition

ChEBI: 3-[({4-[4-({[1-(2-chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid is a member of the class of isoxazoles that is the carbamate ester obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)ethyl hydrogen carbonate with the amino group of 3-({[4-(4-amino-3-methyl-1,2-oxazol-5-yl)phenyl]methyl}sulfanyl)propanoic acid. It is a member of isoxazoles, a carbamate ester, a member of monochlorobenzenes, an organic sulfide and a monocarboxylic acid.

Biochem/physiol Actions

Ki 16425 possesses a short-lived inhibitory activity. It has been studied that Ki 16425 is effective in the inhibition of neuropathic pain‐like behaviors.

storage

Store at +4°C

References

[1]. ohta h, sato k, murata n, damirin a, malchinkhuu e, kon j, kimura t, tobo m, yamazaki y, watanabe t, yagi m, sato m, suzuki r, murooka h, sakai t, nishitoba t, im ds, nochi h, tamoto k, tomura h, okajima f. ki16425, a subtype-selective antagonist for edg-family lysophosphatidic acid receptors. mol pharmacol. 2003 oct;64(4):994-1005.
[2]. ruisanchez é, dancs p, kerék m, németh t, faragó b, balogh a, patil r, jennings bl, liliom k, malik ku, smrcka av, tigyi g, benyó z. lysophosphatidic acid induces vasodilation mediated by lpa1 receptors, phospholipase c, and endothelial nitric oxide synthase. faseb j. 2014 feb;28(2):880-90.
[3]. su sc, hu x, kenney pa, merrill mm, babaian kn, zhang xy, maity t, yang sf, lin x, wood cg. autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma. clin cancer res. 2013 dec 1;19(23):6461-72.
[4]. david m, sahay d, mege f, descotes f, leblanc r, ribeiro j, clézardin p, peyruchaud o. identification of heparin-binding egf-like growth factor (hb-egf) as a biomarker for lysophosphatidic acid receptor type 1 (lpa1) activation in human breast and prostate cancers. plos one. 2014 may 14;9(5):e97771.

KI16425 Preparation Products And Raw materials

Raw materials

Preparation Products

Global Suppliers ( 126)
Supplier Tel Email Country ProdList Advantage
Shanghai Boyle Chemical Co., Ltd. sales@boylechem.com China 2915 55
Chembest Research Laboratories Limited 021-20908456 sales@BioChemBest.com China 5996 61
China Langchem Inc. 0086-21-58956006 China 7798 57
Shanghai Sunway Pharmaceutical Technology Co., Ltd 13761987713 hxzheng@sunwaypharm.cn China 8663 57
BOC Sciences 1-631-485-4226; 16314854226 info@bocsci.com United States 9920 65
Dalian Meilun Biotech Co., Ltd. 0411-62910999 13889544652 sales@meilune.com China 4765 58
Tianjin YongSheng Biotechnology Co., Ltd. 022-60987737 13512258274;13820956092 sales@immortalbio.com China 154 55
NCE Biomedical Co.,Ltd. 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 China 1490 55
China Kouting Group Limited +86 (21) 5811-6473 5811-6475 sales@koutingchina.com China 494 60
Haoyuan Chemexpress Co., Ltd. 021-58950125 info@chemexpress.com China 7545 61

View Latest Price from KI16425 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Ki16425 pictures 2026-06-02 Ki16425
355025-24-0
$52.00-198.00 98.54% 10g TargetMol Chemicals Inc.
  • Ki16425 pictures
  • Ki16425
    355025-24-0
  • $52.00-198.00
  • 98.54%
  • TargetMol Chemicals Inc.

KI16425 Spectrum

CS-88 KI-16425; KI 16425 3-[[[4-[4-[[[1-(2-chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazoly]phenyl]methyl]thio]-propanoic acid 3-[[[4-[4-[[[1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]phenyl]methyl]thio]propanoic acid KI-6425 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl)-3-methylisoxazol-5-yl)benzylthio)propanoic acid Ki16425, >=98% KI16425;KI-16425; KI 16425 3-[[4-[4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-methyl-isoxazol-5-yl]phenyl]methylsulfanyl]propanoic acid 3-((4-(4-(((1-(2-Chlorophenyl)ethoxy)carbonyl)amino)-3-methylisoxazol-5-yl)benzyl)thio)propano Ki 16425, 98%, competitive, potent and reversible antagonist to LPA Debio 0719 Propanoic acid, 3-[[[4-[4-[[[1-(2-chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]phenyl]methyl]thio]- KI16425 USP/EP/BP Ki16425 (Debio 0719) Ki 16425, competitive, potent and reversible antagonist to LPA Ki16425, 10 mM in DMSO Ki16425 ,S1315 355025-24-0 Inhibitors